Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study. 1990

C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
Respiratory Unit C.N.R., University of Perugia, CIBA-GEIGY Clinical Research Department, Rome, Italy.

Cardioselectivity of a single oral dose of metoprolol oral osmotic (OROS) (14/190 mg) and atenolol (100 mg) was compared in 12 patients with reversible obstructive airway disease by assessing the dose-response curve to increasing doses of inhaled salbutamol. The beta-blocking activity of the two drugs, which was determined by measuring heart rate, blood pressure, and derived indexes at peak plasma drug levels, was similar. Both metoprolol and atenolol significantly reduced forced vital capacity and peak expiratory flow, with no difference between drugs. Atenolol but not metoprolol also significantly reduced forced expiratory volume in 1 second and specific airway conductance. Both metoprolol and atenolol shifted the dose-response curve of specific airway conductance to the right. The results indicate that the new OROS delivery system for metoprolol, which produces a relatively constant plasma drug level, provides a cardioselectivity comparable to or greater than that of atenolol at maximum plasma levels.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010366 Peak Expiratory Flow Rate Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR. Expiratory Peak Flow Rate,Flow Rate, Peak Expiratory,PEFR
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
July 1985, Archives of internal medicine,
C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
December 1981, European journal of respiratory diseases,
C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
August 1983, Journal of neurology, neurosurgery, and psychiatry,
C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
April 2012, Headache,
C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
February 1998, Journal of clinical psychopharmacology,
C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
June 1985, Journal of the American College of Cardiology,
C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
November 1991, The American journal of psychiatry,
C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
August 1979, Life sciences,
C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
September 2007, Cephalalgia : an international journal of headache,
C Tantucci, and B Bruni, and M L Dottorini, and F Peccini, and M Motolese, and J B Lecaillon, and C A Sorbini, and V Grassi
January 1987, Drug intelligence & clinical pharmacy,
Copied contents to your clipboard!